What is NUWE's relative strength rating?

NUWE ranks at the 3th percentile over 1 month, 2th percentile over 3 months, 1th percentile over 6 months, 2th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.

What sector is NUWE in?

NUWE is classified under the Healthcare sector within the Medical Equipment industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.

Is NUWE in a leading sector?

Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). NUWE benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.

How volatile is NUWE?

NUWE currently shows a 20-day average daily range (ADR%) of 9.7%, a 90-day beta versus the S&P 500 of 6.87. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does NUWE have a seasonal pattern?

TickerStance computes NUWE's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what NUWE has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did NUWE last report earnings?

NUWE most recently filed a 10-Q covering FY26 Q2 with the SEC on 2026-08-13. TickerStance sources earnings data from SEC EDGAR XBRL submissions and updates the fundamentals panel daily. The Pro dossier shows eight quarters of EPS and revenue trend, operating margin history, and a composite earnings-quality rank.

Nuwellis, Inc. Common Stock (NUWE) · RS 1

TODAY'S READ · AS OF 2026-09-10

As of 2026-09-10, Nuwellis, Inc. Common Stock (NUWE) has a 3-month relative strength percentile of 2 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 20. The current market Stance is 15.8 (Defensive). Sector: Healthcare, ranked 3 of 11. Average daily range 9.7%, relative volume 0.13×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

RS methodology →

Market-wide RS; lit = leaderboard

Lenses lit

3 month2pctile

6 month1pctile

1 year2pctile

Classic1IBD pctile

LDR3leadership

0 of 5 lenses lit · avg RS pctile 2

✓ADR%9.7%✓A/DA!RVOL0.13×✓$ Vol$14M

COMPUTED · AS OF 2026-09-10

Pattern read

NUWE is in a stage 4 downtrend, week 12. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -59.0% / -98.1%.

Pure factual computation. Not a recommendation. See stage analysis.

Market backdrop

15.8Defensive

Trend30% weight37.5 Breadth30% weight28.1 Leadership20% weight12.8 Macro20% weight53.2 Full stance breakdown →

Evidence · 1 of 3

Receipts behind the read

0 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

1m

3

3m

2

6m

1

1y

2

LDR

—

StageWeinstein stage analysis

Stage 4 · Decline✓

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

Fundamentals · NUWE

Does the business back the chart?

SEC EDGAR · last filing 10-Q · FY26 Q2 · period end 2026-06-30

35

Fundamentals Growth Rank

How does growth rank vs. the universe?

vs. 4,465 ranked stocks · Sector rank 40

View fundamental leadership map

Average

Earnings

Are losses narrowing?

Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.

Loss narrowing

$1.74—

24 Q3

$9.30—

24 Q4

Evidence · 2 of 3

Sector context

Healthcare · 82th pctile in sector

Top peers · Healthcare

Who else is leading?

CYPH
99RS 3m
HELP
99RS 3m
NXTC
99RS 3m
NUWE
2RS 3m · you

Sector vs market

Healthcare · 3 of 11

Energy100

Technology91

Healthcare82

Financials

PEERS · Medical Equipment

Same industry, closest relative strength

4 peers · by RS6M

PFSAProfusa, Inc. Common Stock1 PMIPicard Medical, Inc.2 VTAKCatheter Precision, Inc.2 VVOSVivos Therapeutics, Inc. Common Stock2

§ Seasonality

10y · since 2022

Best monthJan on averageavg +22.46% · 50% win · n 4

Worst monthJun on averageavg -41.58% · 20% win · n 5

NUWE monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	NUWE Jan avg: 22.46% median: -3.08% win: 50% σ: 64.35% n: 4 2022-04-12 → 2026-08-31	NUWE Feb avg: -10.65% median: -5.59% win: 50% σ: 37.06% n: 4 2022-04-12 → 2026-08-31	NUWE Mar avg: -33.16% median: -33.92% win: 0% σ: 6.87% n: 4 2022-04-12 → 2026-08-31	NUWE Apr avg: -14.45% median: 0.62% win: 60% σ: 27.82% n: 5 2022-04-12 → 2026-08-31	NUWE May avg: -9.13% median: -24.86% win: 20% σ: 45.62% n: 5 2022-04-12 → 2026-08-31	NUWE Jun avg: -41.58% median: -45.15% win: 20% σ: 41.24% n: 5 2022-04-12 → 2026-08-31	NUWE Jul avg: -18.99% median: -6.69% win: 20% σ: 22.59% n: 5 2022-04-12 → 2026-08-31	NUWE Aug avg: -3.38% median: -46.88% win: 20% σ: 92.87% n: 5 2022-04-12 → 2026-08-31	NUWE Sep avg: -33.75% median: -27.87% win: 0% σ: 20.97% n: 4 2022-04-12 → 2026-08-31 (current)	NUWE Oct avg: -16.55% median: -29.94% win: 25% σ: 43.73% n: 4 2022-04-12 → 2026-08-31	NUWE Nov avg: -24.87% median: -19.20% win: 0% σ: 14.79% n: 4 2022-04-12 → 2026-08-31	NUWE Dec avg: -20.43% median: -20.52% win: 0% σ: 7.56% n: 4 2022-04-12 → 2026-08-31

Public attention · NUWE

Is the crowd watching?

10/ 100 · vs its own 90-day norm▲ 8 vs 7dOverlooked

Weak relative strength and quiet attention. Little to read here either way.

Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.

Company snapshot

SectorHealthcare

IndustryMedical Equipment

SIC3845

Float91Kshares

Shares out3.2Mshares

Market cap$2.4MNano Cap

FAQ

Frequently asked questions

What is NUWE's relative strength rating?: NUWE ranks at the 3th percentile over 1 month, 2th percentile over 3 months, 1th percentile over 6 months, 2th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
What sector is NUWE in?: NUWE is classified under the Healthcare sector within the Medical Equipment industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.
Is NUWE in a leading sector?: Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). NUWE benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.
How volatile is NUWE?: NUWE currently shows a 20-day average daily range (ADR%) of 9.7%, a 90-day beta versus the S&P 500 of 6.87. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does NUWE have a seasonal pattern?: TickerStance computes NUWE's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what NUWE has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

Nuwellis, Inc. Common Stock (NUWE) — Stance & relative strength

Lenses lit

Pattern read

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Are losses narrowing?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

§ Seasonality

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?

Is revenue confirming?

Are margins expanding?

Share count: tailwind or headwind?

§ Seasonality

Nuwellis, Inc. Common Stock (NUWE) — Stance & relative strength

NUWE is not confirmed as a leader. 2 is not yet a leadership-grade RS read, Market Stance is 15.8

Lenses lit

Pattern read

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Are losses narrowing?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?

Is revenue confirming?

Are margins expanding?

Share count: tailwind or headwind?